Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from FWD Group Holdings Limited ( (HK:1828) ) is now available.
FWD Group Holdings has issued a clarification on its recent grant of share awards under its Share Award Plan, correcting clerical errors in the figures previously disclosed. The company now states that it granted a total of 6,088,294 restricted share units and 7,974,702 performance share units, with 365,292 RSUs and 913,230 PSUs allocated to Group CEO and executive director Huynh Thanh Phong, and confirms that the total grant covers 14,062,996 share awards while the number of shares remaining available for future grants under its mandates has been adjusted accordingly.
The clarification primarily affects the reported size of awards to senior management and the residual capacity under the group’s share plan limits, but does not change the substance of the original incentive program. By promptly rectifying the disclosure, FWD aims to maintain transparency around equity‑based compensation, a key tool for aligning leadership incentives with shareholder interests in the competitive Asian insurance market.
The most recent analyst rating on (HK:1828) stock is a Buy with a HK$48.00 price target. To see the full list of analyst forecasts on FWD Group Holdings Limited stock, see the HK:1828 Stock Forecast page.
More about FWD Group Holdings Limited
FWD Group Holdings Limited is a Hong Kong‑listed insurance group incorporated in the Cayman Islands. The company operates in the life and health insurance sector across Asia, with its board comprising executive, non‑executive and independent non‑executive directors overseeing regional growth and governance.
Average Trading Volume: 546,147
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$39.03B
For detailed information about 1828 stock, go to TipRanks’ Stock Analysis page.

